BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kontogianni-Katsarou K, Dimitriadis E, Lariou C, Kairi-Vassilatou E, Pandis N, Kondi-Paphiti A. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World J Gastroenterol 2008; 14(12): 1891-1897 [PMID: 18350628 DOI: 10.3748/wjg.14.1891]
URL: https://www.wjgnet.com/1007-9327/full/v14/i12/1891.htm
Number Citing Articles
1
Afia Muhammad Akram, Mubashir Hassan, Asma Chaudhary, Sikandar Hayat, Qurban Ali, Taha Hussain, Amjad Zafar, Muhammad Arshad Javed. Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patientsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23934-y
2
Yue-Ying Wang, Li-Juan Zhao, Chuan-Feng Wu, Ping Liu, Lin Shi, Yang Liang, Shu-Min Xiong, Jian-Qing Mi, Zhu Chen, Ruibao Ren, Sai-Juan Chen. C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in miceProceedings of the National Academy of Sciences 2011; 108(6): 2450 doi: 10.1073/pnas.1019625108
3
Joseph A. Holden, Carlynn Willmore-Payne, Lester J. Layfield. Gastrointestinal Stromal Tumors: A Guide to the DiagnosisSurgical Pathology Clinics 2010; 3(2): 241 doi: 10.1016/j.path.2010.05.008
4
Alexander W. Beham, Inga-Marie Schaefer, Philipp Schüler, Silke Cameron, B. Michael Ghadimi. Gastrointestinal stromal tumorsInternational Journal of Colorectal Disease 2012; 27(6): 689 doi: 10.1007/s00384-011-1353-y
5
Kemal Kosemehmetoglu, Gulsah Kaygusuz, Karen Fritchie, Ovgu Aydin, Ozlem Yapicier, Oznur Coskun, Ersin Karatayli, Senay Boyacigil, Gulnur Guler, Sergulen Dervisoglu, Isinsu Kuzu. Clinical and pathological characteristics of gastrointestinal stromal tumor (GIST) metastatic to boneVirchows Archiv 2017; 471(1): 77 doi: 10.1007/s00428-017-2138-7
6
Jerzy Lasota, Wojciech Kuban, Eva Wardelmann, Maria Debiec-Rychter, Sabine Merkelbach-Bruse, Raf Sciot, Janusz Rys, Sonja E. Steigen, Katarzyna Iwanik, Joseph A. Holden, Anna Jerzak vel Dobosz, Hans-Ulrich Schildhaus, Markku Miettinen. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutantsHuman Pathology 2008; 39(12): 1728 doi: 10.1016/j.humpath.2008.05.011
7
Annarosaria De Chiara, Angelo Paolo Dei Tos. GISTs — Gastrointestinal Stromal Tumors2011; : 3 doi: 10.1007/978-88-470-1869-3_1
8
M.İsa Kara, Sinan Ay, Fahrettin Goze, Mehri İgci, Sahende Elagoz, Beyhan Cengiz. Genetic analysis of intraoral KIT-positive gastrointestinal stromal tumor (GIST)Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2010; 110(4): 498 doi: 10.1016/j.tripleo.2010.04.044
9
Minh Phan, Shari Jones, Justin Jenkins, Shubham Pant, Mohamad Khawandanah. Pancreatic GIST in a Patient with Limited Stage Small Cell Lung Cancer: A Case Report and Review of Published CasesCase Reports in Oncological Medicine 2016; 2016: 1 doi: 10.1155/2016/9604982
10
Niraj Kumari, Valli Priyaa, Pooja Shukla, Ashok Kumar, Rakesh Aggarwal, Narendra Krishnani. Gastrointestinal Stromal Tumor: Genotype Frequency and Prognostic RelevanceApplied Immunohistochemistry & Molecular Morphology 2018; 26(3): 153 doi: 10.1097/PAI.0000000000000395
11
Jason S Gold, Mithat Gönen, Antonio Gutiérrez, Javier Martín Broto, Xavier García-del-Muro, Thomas C Smyrk, Robert G Maki, Samuel Singer, Murray F Brennan, Cristina R Antonescu, John H Donohue, Ronald P DeMatteo. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysisThe Lancet Oncology 2009; 10(11): 1045 doi: 10.1016/S1470-2045(09)70242-6
12
R. L. Jones. Practical Aspects of Risk Assessment in Gastrointestinal Stromal TumorsJournal of Gastrointestinal Cancer 2014; 45(3): 262 doi: 10.1007/s12029-014-9615-x
13
Pieter A. Boonstra, Jourik A. Gietema, Albert J.H. Suurmeijer, Matthew R. Groves, Fernando de Assis Batista, Ed Schuuring, Anna K.L. Reyners. Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literatureOncotarget 2017; 8(65): 109836 doi: 10.18632/oncotarget.22663
14
Leonidas Mavroeidis, Vassiliki Metaxa-Mariatou, Alexandra Papoudou-Bai, Angeliki Maria Lampraki, Lida Kostadima, Ilias Tsinokou, George Zarkavelis, Alexandra Papadaki, Dimitrios Petrakis, Stefania Gκoura, Eleftherios Kampletsas, George Nasioulas, Anna Batistatou, George Pentheroudakis. Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western GreeceESMO Open 2018; 3(3): e000335 doi: 10.1136/esmoopen-2018-000335
15
Marcelle R. Cerski, Fernanda Pereira, Ursula S. Matte, Francine H. Oliveira, Felipe L. Crusius, Luiz E. Waengertner, Alessandro Osvaldt, Fernando Fornari, Luise Meurer. Exon 11 mutations, Ki67, and p16INK4A as predictors of prognosis in patients with GISTPathology - Research and Practice 2011; 207(11): 701 doi: 10.1016/j.prp.2011.09.008
16
Angela Michelucci, Caterina Chiappetta, Jessica Cacciotti, Norman Veccia, Elisa Astri, Martina Leopizzi, Romana Prosperi Porta, Vincenzo Petrozza, Carlo Della Rocca, Generoso Bevilacqua, Andrea Cavazzana, Claudio Di Cristofano. The KIT Exon 11 Stop Codon Mutation in Gastrointestinal Stromal Tumors: What Is the Clinical Meaning?Gut and Liver 2013; 7(1): 35 doi: 10.5009/gnl.2013.7.1.35
17
Bruno Vincenzi, Margherita Nannini, Elena Fumagalli, Giuseppe Bronte, Anna Maria Frezza, Delia De Lisi, Mariella Spalato Ceruso, Daniele Santini, Giuseppe Badalamenti, Maria Abbondanza Pantaleo, Antonio Russo, Angelo Paolo Dei Tos, Paolo Casali, Giuseppe Tonini. Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysisOncotarget 2016; 7(43): 69412 doi: 10.18632/oncotarget.5136
18
Lester J. Layfield, Michelle L. Wallander. Diagnosis of gastrointestinal stromal tumors from minute specimens: Cytomorphology, immunohistochemistry, and molecular diagnostic findingsDiagnostic Cytopathology 2012; 40(6): 484 doi: 10.1002/dc.22838
19
Jennifer M. Racz, Savtaj S. Brar, Michelle C. Cleghorn, M. Carolina Jimenez, Arash Azin, Eshetu G. Atenafu, Timothy D. Jackson, Allan Okrainec, Fayez A. Quereshy. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumorsJournal of Surgical Oncology 2015; 111(4): 371 doi: 10.1002/jso.23839
20
Bruno Vincenzi, Margherita Nannini, Giuseppe Badalamenti, Giovanni Grignani, Elena Fumagalli, Silvia Gasperoni, Lorenzo D’Ambrosio, Lorena Incorvaia, Marco Stellato, Mariella Spalato Ceruso, Andrea Napolitano, Sergio Valeri, Daniele Santini, Giuseppe Tonini, Paolo Giovanni Casali, Angelo Paolo Dei Tos, Maria Abbondanza Pantaleo. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenibTherapeutic Advances in Medical Oncology 2018; 10: 175883591879462 doi: 10.1177/1758835918794623
21
J R Todd, L L Scurr, T M Becker, R F Kefford, H Rizos. The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanomaOncogene 2014; 33(2): 236 doi: 10.1038/onc.2012.562
22
Lin Yan, Lei Zou, Wenhua Zhao, Yansen Wang, Bo Liu, Hongliang Yao, Haihua Yu. Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysisScientific Reports 2015; 5(1) doi: 10.1038/srep13718
23
Anna Patrikidou, Julien Domont, Sylvie Chabaud, Isabelle Ray-Coquard, Jean-Michel Coindre, Binh Bui-Nguyen, Antoine Adenis, Maria Rios, François Bertucci, Florence Duffaud, Christine Chevreau, Didier Cupissol, David Pérol, Jean-François Emile, Jean-Yves Blay, Axel Le Cesne. Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma GroupEuropean Journal of Cancer 2016; 52: 173 doi: 10.1016/j.ejca.2015.10.069
24
P. Origone, S. Gargiulo, L. Mastracci, A. Ballestrero, L. Battistuzzi, C. Casella, D. Comandini, R. Cusano, A. P. Dei Tos, R. Fiocca, A. Garuti, P. Ghiorzo, C. Martinuzzi, L. Toffolatti, G. Bianchi Scarrà. Molecular characterization of an Italian series of sporadic GISTsGastric Cancer 2013; 16(4): 596 doi: 10.1007/s10120-012-0213-y
25
Joshua Anspach Hanson, Jonathan C. Trent, Dan Yang, Kumarasen Cooper. Small-Intestinal Rhabdoid Gastrointestinal Stromal Tumor (GIST)International Journal of Surgical Pathology 2011; 19(5): 653 doi: 10.1177/1066896911404413
26
Chao Wang, Mei-Shan Jin, Ya-Bin Zou, Jing-Na Gao, Xiao-Bo Li, Fang Peng, Hai-Ying Wang, Zhen-Dong Wu, Yin-Ping Wang, Xiu-Mei Duan. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumoursScandinavian Journal of Gastroenterology 2013; 48(9): 1055 doi: 10.3109/00365521.2013.816770
27
Riccardo Ricci, Maurizio Martini, Tonia Cenci, Armando Antinori, Alessandra Cassano, Luigi M. Larocca. Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually ExclusiveJournal of Clinical Oncology 2016; 34(12): e107 doi: 10.1200/JCO.2013.49.1258
28
Yuyang Feng, Surui Yao, Zhening Pu, Han Cheng, Bojian Fei, Jian Zou, Zhaohui Huang. Identification of New Tumor-Related Gene Mutations in Chinese Gastrointestinal Stromal TumorsFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.764275
29
Rodney E. Shackelford, Maisoun Qassim Abdelbaqi, Khaldoon Almhanna, Kenneth Meredith, Domenico Coppola. Molecular Pathology and Diagnostics of Cancer2014; : 177 doi: 10.1007/978-94-007-7192-5_6